Journal Information

Statistics

Follow this link to access the full text of the article

Araújo A, et al. An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer Rev Port Pneumol 2008; 14(6):803–827
Araújo A, et al. Avaliação económica do erlotinib, docetaxel, pemetrexedo e tratamento de suporte no tratamento de segunda ou terceira linhas de doentes com cancro do pulmão de não pequenas células Rev Port Pneumol 2008; 14(6):803–827
Wojciech Bartminski
European Outcomes Research, Health Outcomes Scientist, Oncology & Neuroscience, EMS AREA
Read
1343
Times
was read the article
722
Total PDF
621
Total HTML
Share statistics
Article information
ISSN: 21735115
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 6 7 3 10
2025 5 48 51 99
2025 4 41 36 77
2025 3 37 34 71
2025 2 32 34 66
2025 1 20 31 51
2024 12 19 34 53
2024 11 36 51 87
2024 10 23 29 52
2024 9 28 28 56
2024 8 49 34 83
2024 7 25 25 50
2024 6 19 21 40
2024 5 21 37 58
2024 4 22 17 39
2024 3 20 14 34
2024 2 18 23 41
2024 1 17 28 45
2023 12 13 14 27
2023 11 22 29 51
2023 10 12 30 42
2023 9 15 28 43
2023 8 23 25 48
2023 7 18 27 45
2023 6 13 8 21
2023 5 18 24 42
2023 4 5 7 12
Show all

Follow this link to access the full text of the article

Pulmonology

Are you a health professional able to prescribe or dispense drugs?